263 related articles for article (PubMed ID: 37507573)
1. Procalcitonin and C-reactive protein to rule out early bacterial coinfection in COVID-19 critically ill patients.
Galli F; Bindo F; Motos A; Fernández-Barat L; Barbeta E; Gabarrús A; Ceccato A; Bermejo-Martin JF; Ferrer R; Riera J; Peñuelas O; Lorente JÁ; de Gonzalo-Calvo D; Menéndez R; Gonzalez J; Misuraca S; Palomeque A; Amaya-Villar R; Añón JM; Balan Mariño A; Barberà C; Barberán J; Blandino Ortiz A; Bustamante-Munguira E; Caballero J; Cantón-Bulnes ML; Carbajales Pérez C; Carbonell N; Catalán-González M; de Frutos R; Franco N; Galbán C; Lopez Lago A; Gumucio-Sanguino VD; de la Torre MDC; Díaz E; Estella Á; Gallego Curto E; García-Garmendia JL; Gómez JM; Huerta A; Jorge García RN; Loza-Vázquez A; Marin-Corral J; Martin Delgado MC; Martínez de la Gándara A; Martínez Varela I; Lopez Messa J; M Albaiceta G; Nieto MT; Novo MA; Peñasco Y; Pérez-García F; Pozo-Laderas JC; Ricart P; Sagredo V; Sánchez-Miralles A; Sancho Chinesta S; Roche-Campo F; Socias L; Solé-Violan J; Suarez-Sipmann F; Tamayo Lomas L; Trenado J; Úbeda A; Valdivia LJ; Vidal P; Boado MV; Rodríguez A; Antonelli M; Blasi F; Barbé F; Torres A;
Intensive Care Med; 2023 Aug; 49(8):934-945. PubMed ID: 37507573
[TBL] [Abstract][Full Text] [Related]
2. Negative predictive value of procalcitonin to rule out bacterial respiratory co-infection in critical covid-19 patients.
Carbonell R; Urgelés S; Salgado M; Rodríguez A; Reyes LF; Fuentes YV; Serrano CC; Caceres EL; Bodí M; Martín-Loeches I; Solé-Violán J; Díaz E; Gómez J; Trefler S; Vallverdú M; Murcia J; Albaya A; Loza A; Socias L; Ballesteros JC; Papiol E; Viña L; Sancho S; Nieto M; Del M; Lorente C; Badallo O; Fraile V; Arméstar F; Estella A; Abanses P; Sancho I; Guasch N; Moreno G;
J Infect; 2022 Oct; 85(4):374-381. PubMed ID: 35781017
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of Procalcitonin's Utility to Predict Concomitant Bacterial Pneumonia in Critically Ill COVID-19 Patients.
Patel N; Adams C; Brunetti L; Bargoud C; Teichman AL; Choron RL
J Intensive Care Med; 2022 Nov; 37(11):1486-1492. PubMed ID: 35711161
[No Abstract] [Full Text] [Related]
4. Dexamethasone and tocilizumab treatment considerably reduces the value of C-reactive protein and procalcitonin to detect secondary bacterial infections in COVID-19 patients.
Kooistra EJ; van Berkel M; van Kempen NF; van Latum CRM; Bruse N; Frenzel T; van den Berg MJW; Schouten JA; Kox M; Pickkers P
Crit Care; 2021 Aug; 25(1):281. PubMed ID: 34353339
[TBL] [Abstract][Full Text] [Related]
5. Searching for a role of procalcitonin determination in COVID-19: a study on a selected cohort of hospitalized patients.
Dolci A; Robbiano C; Aloisio E; Chibireva M; Serafini L; Falvella FS; Pasqualetti S; Panteghini M
Clin Chem Lab Med; 2020 Nov; 59(2):433-440. PubMed ID: 33554505
[TBL] [Abstract][Full Text] [Related]
6. C-reactive protein and procalcitonin for antimicrobial stewardship in COVID-19.
Pink I; Raupach D; Fuge J; Vonberg RP; Hoeper MM; Welte T; Rademacher J
Infection; 2021 Oct; 49(5):935-943. PubMed ID: 34021897
[TBL] [Abstract][Full Text] [Related]
7. High procalcitonin levels associated with increased intensive care unit admission and mortality in patients with a COVID-19 infection in the emergency department.
Tong-Minh K; van der Does Y; Engelen S; de Jong E; Ramakers C; Gommers D; van Gorp E; Endeman H
BMC Infect Dis; 2022 Feb; 22(1):165. PubMed ID: 35189826
[TBL] [Abstract][Full Text] [Related]
8. The Association of Procalcitonin and C-Reactive Protein with Bacterial Infections Acquired during Intensive Care Unit Stay in COVID-19 Critically Ill Patients.
Campani S; Talamonti M; Dall'Ara L; Coloretti I; Gatto I; Biagioni E; Tosi M; Meschiari M; Tonelli R; Clini E; Cossarizza A; Guaraldi G; Mussini C; Sarti M; Trenti T; Girardis M;
Antibiotics (Basel); 2023 Oct; 12(10):. PubMed ID: 37887237
[TBL] [Abstract][Full Text] [Related]
9. Procalcitonin and C-reactive protein as diagnostic biomarkers in COVID-19 and Non-COVID-19 sepsis patients: a comparative study.
Shi J; Zhuo Y; Wang TQ; Lv CE; Yao LH; Zhang SY
BMC Infect Dis; 2024 Jan; 24(1):45. PubMed ID: 38172766
[TBL] [Abstract][Full Text] [Related]
10. Comparison of procalcitonin with C-reactive protein and serum amyloid for the early diagnosis of bacterial sepsis in critically ill neonates and children.
Enguix A; Rey C; Concha A; Medina A; Coto D; Diéguez MA
Intensive Care Med; 2001 Jan; 27(1):211-5. PubMed ID: 11280637
[TBL] [Abstract][Full Text] [Related]
11. Bacterial and Fungal Coinfection in Critically Ill COVID-19 Cases and Predictive Role of Procalcitonin During the First Wave at an Academic Health Center.
Alnimr AM; Alshahrani MS; Alwarthan S; AlQahtani SY; Hassan AA; BuMurah NN; Alhajiri S; Bukharie H
J Epidemiol Glob Health; 2022 Jun; 12(2):188-195. PubMed ID: 35397070
[TBL] [Abstract][Full Text] [Related]
12. C-reactive protein or procalcitonin combined with rhinorrhea for discrimination of viral from bacterial infections in hospitalized adults in non-intensive care units with lower respiratory tract infections.
Duan S; Gu X; Fan G; Zhou F; Zhu G; Cao B
BMC Pulm Med; 2021 Sep; 21(1):308. PubMed ID: 34583675
[TBL] [Abstract][Full Text] [Related]
13. [Value of Hepcidin as a diagnostic biomarker of sepsis in critically ill adults].
Qiu Z; Shen K; Shu M; Xu D; Deng X; Chen D
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2018 Jul; 30(7):652-657. PubMed ID: 30045792
[TBL] [Abstract][Full Text] [Related]
14. Measuring both procalcitonin and C-reactive protein for a diagnosis of sepsis in critically ill patients.
Li HX; Liu ZM; Zhao SJ; Zhang D; Wang SJ; Wang YS
J Int Med Res; 2014 Aug; 42(4):1050-9. PubMed ID: 24827825
[TBL] [Abstract][Full Text] [Related]
15. Procalcitonin (PCT) levels for ruling-out bacterial coinfection in ICU patients with influenza: A CHAID decision-tree analysis.
Rodríguez AH; Avilés-Jurado FX; Díaz E; Schuetz P; Trefler SI; Solé-Violán J; Cordero L; Vidaur L; Estella Á; Pozo Laderas JC; Socias L; Vergara JC; Zaragoza R; Bonastre J; Guerrero JE; Suberviola B; Cilloniz C; Restrepo MI; Martín-Loeches I;
J Infect; 2016 Feb; 72(2):143-51. PubMed ID: 26702737
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic yield of bacteriological tests and predictors of severe outcome in adult patients with COVID-19 presenting to the emergency department.
Kaal A; Snel L; Dane M; van Burgel N; Ottens T; Broekman W; El Bouazzaoui L; Kolfschoten N; Schippers E; Steyerberg E; Meziyerh S; van Nieuwkoop C
Emerg Med J; 2021 Sep; 38(9):685-691. PubMed ID: 34289966
[TBL] [Abstract][Full Text] [Related]
17. Combination of procalcitonin and C-reactive protein levels in the early diagnosis of bacterial co-infections in children with H1N1 influenza.
Li Z; He L; Li S; He W; Zha C; Ou W; Hou Q; Wang W; Sun X; Liang H
Influenza Other Respir Viruses; 2019 Mar; 13(2):184-190. PubMed ID: 30443990
[TBL] [Abstract][Full Text] [Related]
18. Characteristics of procalcitonin in hospitalized COVID-19 patients and clinical outcomes of antibiotic use stratified by procalcitonin levels.
So W; Simon MS; Choi JJ; Wang TZ; Williams SC; Chua J; Kubin CJ
Intern Emerg Med; 2022 Aug; 17(5):1405-1412. PubMed ID: 35277828
[TBL] [Abstract][Full Text] [Related]
19. Procalcitonin to predict bacterial coinfection in infants with acute bronchiolitis: a preliminary analysis.
Laham JL; Breheny PJ; Gardner BM; Bada H
Pediatr Emerg Care; 2014 Jan; 30(1):11-5. PubMed ID: 24365727
[TBL] [Abstract][Full Text] [Related]
20. Value of Procalcitonin Measurement for Early Evidence of Severe Bacterial Infections in the Pediatric Intensive Care Unit.
Lautz AJ; Dziorny AC; Denson AR; O'Connor KA; Chilutti MR; Ross RK; Gerber JS; Weiss SL
J Pediatr; 2016 Dec; 179():74-81.e2. PubMed ID: 27587074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
